Protein-ligand binding is among the most fundamental phenomena underlying all molecular biology, and a greater ability to more accurately and robustly predict the binding free energy of a small molecule ligand for its cognate protein is expected to have vast consequences for improving the efficiency of pharmaceutical drug discovery. We briefly reviewed a number of scientific and technical advances that have enabled alchemical free energy calculations to recently emerge as a preferred approach, and critically considered proper validation and effective use of these techniques. In particular, we characterized a selection bias effect which may be important in prospective free energy calculations, and introduced a strategy to improve the accuracy of the free energy predictions.
Keywords: Alchemical free energy calculations; Computer-aided drug design; Drug discovery; FEP; Free energy; Molecular dynamics; Protein-ligand binding; Structure-based drug discovery; TI; Thermodynamic integration.
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].